Q2 2026 · 1 tracked holders Snapshot · 16 Nov 2026 Export CSV
Security file · CUSIP 36269B105

GANX

GAIN THERAPEUTICS INC · US listing · held by 1 tracked manager in Q2 2026.

Tracked holders · Q2 2026
1
+0 vs Q1 2026
Aggregate reported value
$1.15M
sum of holders' reported positions
New holders this quarter
0
0 added · 0 trimmed
Holder return since filing
-54.2%
weighted by each holder's position share · since filing
Ownership · Q2 2026
ManagerWeight SharesΔ shares Entry Return ValueActivity
1 David Einhorn - Greenlight Capitalfiled 14 Aug ET 0.03% 566K +0.0% $2 -54.2% $1.15M Held
Holder count
Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 20261
Aggregate reported value
Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026$2.13M
Quarterly aggregation
QuarterHoldersΔ holdersAggregate valueTotal shares
Q2 2026 1 +0 $1.15M 566K
Q1 2026 1 +0 $1.10M 566K
Q4 2025 1 +0 $1.82M 566K
Q3 2025 1 +0 $1.00M 566K
Q2 2025 1 +0 $1.02M 566K
Q1 2025 1 +0 $1.08M 566K
Q4 2024 1 +0 $1.22M 566K
Q3 2024 1 +0 $1.01M 566K
Q2 2024 1 +0 $725K 566K
Q1 2024 1 — $2.13M 566K